Adult vaccine outreach: shingles, pneumococcal and RSV pages, the ACIP court stay, Medicare Part B and Part D, and recall texts

Adult vaccine outreach asks a person who feels well to book a shot against an illness they may never have had, and the reasons and the costs differ from one vaccine to the next. Shingles, pneumococcal and RSV vaccines are the three that primary care offices, internal medicine and geriatric practices, pharmacies, pulmonology and cardiology practices, senior living communities and health fairs promote to adults. The federal positions on who should get them are written down, but the detail goes wrong in marketing: an age range that has moved, a vaccine sold as preventing a disease its sources do not name, “free” with no condition, a recall text that tells a household why the patient qualifies, or a page that does not mention that the federal committee behind the recommendations has been in court since 2025. This guide covers how to build vaccine pages on the CDC wording with dates, how to handle the court stay that affects the Advisory Committee on Immunization Practices (ACIP), how to explain Medicare Part B and Part D coverage, how to word recall texts, and which claims to leave out.

Nine related topics have their own guides and are not repeated here. Flu shots are covered in our guide to flu shot clinic marketing, and other vaccine programs in our guides to hepatitis B screening and vaccination outreach, cervical cancer screening and HPV vaccine outreach, travel medicine clinic marketing and Vaccines for Children provider marketing. Practices and settings that give adult vaccines are covered in our guides to primary care practice marketing, annual wellness visit outreach, independent pharmacy marketing and nursing home marketing.

What the federal sources say

The CDC publishes the adult immunization schedule and the vaccine pages, the ACIP advises the CDC on them, FDA licenses the vaccines, and Medicare.gov says what Medicare pays for. The points that shape an adult vaccine program’s marketing:

• The CDC Adult Immunization Schedule by Age (2025 schedule, addendum updated July 2, 2025, read through an archived copy) was still the current adult schedule on the CDC site when we read it in October 2026. It lists shingles vaccination as 2 doses at age 50 and older and for adults 19 and older with immunocompromising conditions, pneumococcal vaccination by age and risk with the details in its notes, and RSV vaccination for adults 75 and older and for adults 50 through 74 at increased risk.
• The CDC page Shingles Vaccination (July 19, 2024, read through an archived copy) recommends 2 doses for adults 50 and older, separated by 2 to 6 months, and 2 doses for adults 19 and older with weakened immune systems due to disease or therapy. It says there is no maximum age, and that a person should still get the vaccine after having shingles, after an older shingles vaccine or after a chickenpox vaccine.
• The CDC page Pneumococcal Vaccination (February 25, 2026, read through an archived copy) recommends pneumococcal vaccination for all adults 50 or older and adults 19 through 49 with certain risk conditions, and says the vaccines work well but cannot prevent all cases.
• The CDC page RSV Vaccine Guidance for Adults (February 20, 2026, read through an archived copy) recommends an RSV vaccine for all adults 75 and older and for adults 50 through 74 at increased risk of severe RSV illness. It says the vaccine is a single dose, is not an annual vaccine, and that a person who has already had one should not get another at this time, and that the best time to get it is late summer and early fall.
• The Medicare.gov pages Pneumococcal vaccines, Shingles vaccines and RSV shot, checked on October 30, 2026, say Part B covers pneumococcal vaccines and the person pays nothing if the provider accepts assignment, and that Part D covers shingles and RSV vaccines and the person pays nothing if they have Part D.

The committee behind these recommendations is in a court case. The Congressional Research Service report The 2026 Childhood Immunization Schedule (June 11, 2026) says that on March 16, 2026 a federal district court stayed the revised 2026 childhood schedule, and also stayed the appointments of 13 ACIP members appointed by the HHS Secretary and their votes at ACIP meetings in 2025. It says the government appealed to the First Circuit on April 29, 2026, and that HHS filed a notice to reestablish ACIP on May 19, 2026. The CRS Legal Sidebar CDC’s Updated Childhood Vaccine Schedule: Litigation and Potential Implications for Vaccine Injury Compensation Program (May 4, 2026) describes the same case. The CDC ACIP Meeting Information page (updated October 9, 2026, read through an archived copy) lists the March, June and October 2026 ACIP meetings as cancelled due to ongoing litigation.

One adult recommendation is caught in this. The CDC Adult Immunization Schedule Addendum (updated July 2, 2025, read through an archived copy) lists the ACIP recommendation of June 25, 2025 that adults 50 through 59 at increased risk of severe RSV disease receive a single dose, which is where the lower end of the 50 through 74 range comes from. That vote was taken at one of the 2025 meetings the CRS report describes. The archived CDC pages we read in October 2026 still showed the 50 through 74 range, and we could not confirm from a primary source how the stay applies to that recommendation or what has happened in the case since June 2026. The shingles and pneumococcal recommendations quoted above, and the RSV recommendation for adults 75 and older, are not tied to a 2025 vote in the sources we read. Until the case settles, an RSV page for adults 50 through 59 should quote the CDC page with its date, say the practice checks the current CDC guidance and the patient’s coverage before the visit, and leave the decision to the clinician and patient. Ask counsel before any page states that the recommendation for that age group is settled.

We also checked the vaccine list against FDA’s records, because older pages can trail newer licenses. The FDA list Vaccines Licensed for Use in the United States (content current as of October 8, 2026) lists three RSV vaccines, a recombinant shingles vaccine and several pneumococcal vaccines. The CDC pages describe the same vaccines, so there is no “no vaccine available” wording to correct. Name no vaccine by brand on a marketing page; let the clinician choose the product.

Two points shape the marketing. First, an FDA license and a CDC recommendation are different things. FDA’s notice of January 7, 2025 says one RSV vaccine was approved for people 18 through 59 at increased risk, while the CDC recommendation starts at 50; a page that reads “approved for adults 18 and up” invites people the recommendation and the coverage may not reach. Second, coverage follows the recommendation. Medicare Part D’s no-cost rule and the private plan rule in 42 U.S.C. 300gg-13 both point to ACIP recommendations, so a change in the recommendation can change the cost to the patient.

Vaccine pages and claims that need rewriting

Google’s search suggestions, which we checked on October 30, 2026, offer “shingles vaccine side effects”, “shingles vaccine schedule”, “shingles vaccine age”, “shingles vaccine cost” and “shingles vaccine near me” to a person who types “shingles vaccine”, “shingles vaccine for under 50”, “shingles vaccine for immunocompromised”, “shingles vaccine for people who never had chickenpox” and “shingles vaccine for dementia” after “shingles vaccine for”, “pneumonia vaccine side effects”, “pneumonia vaccine age” and “pneumonia vaccine schedule” after “pneumonia vaccine”, and “rsv vaccine for adults”, “rsv vaccine side effects”, “rsv vaccine age” and “rsv vaccine for seniors” after “rsv vaccine”. A page can answer each of those from the CDC pages with their dates: who the vaccine is for, the number of doses and their timing, what side effects CDC lists, what Medicare and the patient’s plan pay, and where to book.

A page that holds up names the vaccine by the disease it prevents, says who CDC recommends it for in CDC’s words and with the page date, gives the number of doses and whether it repeats, lists the side effects CDC lists, explains which part of Medicare covers it, and tells the reader to talk with the clinician about their own history. It links the CDC page for each vaccine. It also has to work for older readers: large text that resizes, strong contrast and a phone number next to the booking button, as our guide to website accessibility for medical practices explains.

Phrases that need rewriting:

• “The shingles shot prevents dementia.” The CDC shingles pages we read describe protection against shingles and the long-term nerve pain that can follow it, and say nothing about dementia. Remove the claim, and answer the “shingles vaccine for dementia” search by saying the vaccine is recommended to prevent shingles and that questions about other research belong with the clinician.
• “The pneumonia shot means you won’t get pneumonia.” Medicare.gov says pneumococcal vaccines protect against different strains of the bacteria that cause pneumonia, and CDC says the vaccines cannot prevent all cases. Call it a pneumococcal vaccine and say what it protects against.
• “Get your RSV shot every fall.” CDC says the RSV vaccine is not an annual vaccine and that a person who has had one should not get another at this time. Say it is a single dose and ask the patient whether they have had one.
• “RSV vaccine for everyone 50 and up.” CDC recommends it for all adults 75 and older and for adults 50 through 74 at increased risk, and the 50 through 59 part is tied to the court case above. Quote the CDC ages and date, and say the clinician checks whether the patient qualifies.
• “FDA-approved for all adults.” Licensed ages and recommended ages differ. Quote the CDC recommendation for who should get the vaccine, and do not use the label’s age range to widen it.
• “No side effects” or “completely safe.” CDC lists side effects for each vaccine, and FDA added a Guillain-Barré syndrome warning to the prescribing information of two RSV vaccines in January 2025. List the side effects CDC lists, with the date, and send questions to the clinician.
• “Free shingles shot with Medicare.” Medicare.gov says the person pays nothing if they have Part D. Say “no cost with Medicare Part D drug coverage” and that the practice checks coverage before the visit.
• “Boost your immunity with our vitamin pack.” A supplement claim with no source. Remove it, and follow the supplement section below.
• “We’ve protected thousands of seniors.” Numbers with no source. Remove them unless they are drawn from the practice’s own documented and reviewed records, with their date and limits stated.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. Quoting the federal sources as written, with each one named and dated, stays inside that standard; turning a federal statement into a promise to the reader does not. When an outbreak is in the news, our guide to advertising during an outbreak or flu season covers prevention claims, test ads, emergency pricing and texts.

Symptoms, urgent signs and 911 on every page and in every tool

Vaccine pages are for people who feel well, so the page has to send people who are sick or reacting elsewhere. The CDC shingles page says a person who has shingles now should wait to get the vaccine, and the CDC RSV page says a person with a moderate or severe illness should wait until they recover. Put plain lines above the booking button and on flyers: if you are sick now, or you have a rash, call [phone] before you come in; if you have a reaction after a vaccine that worries you, call [phone]; call 911 for an emergency. The CDC RSV page also says side effects can be reported to the Vaccine Adverse Event Reporting System, and a practice page can say the practice files those reports or helps patients file them.

The same wording belongs in voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, and on cards handed out at a vaccine event. A tool should hand any message about a reaction after a shot to a clinician or the on-call line, send any message about an emergency to the 911 line and alert staff, pass questions about whether a patient qualifies to a clinician, and never tell a patient whether they need a vaccine. Our guides to the AI chatbot on a practice website and answering service versus AI receptionist cover how tools hand off these messages.

Shingles vaccine pages

Shingles pages draw the “shingles vaccine age”, “shingles vaccine schedule”, “shingles vaccine for under 50” and “shingles vaccine for people who never had chickenpox” searches. Answer each from the CDC page with its date: 2 doses at age 50 and older, 2 to 6 months apart; 2 doses for adults 19 and older with weakened immune systems due to disease or therapy; no maximum age; still recommended after having shingles. For chickenpox, CDC says a person can get the vaccine whether or not they remember having had chickenpox, and that adults with weakened immune systems and no record of chickenpox, chickenpox vaccine or shingles should talk with their clinician. Quote that and leave the decision to the clinician.

Keep these points:

• Say the series is 2 doses and that the second dose matters. A reminder for the second dose is part of the program, not an extra.
• For adults under 50, do not suggest the vaccine is for everyone. Say CDC recommends it for adults 19 and older with weakened immune systems, and that the clinician decides who qualifies.
• List the side effects CDC lists, including a sore arm, redness and swelling, tiredness, muscle pain, headache, shivering, fever, stomach pain and nausea, and say CDC notes they may temporarily keep a person from regular activities. Telling patients this helps them plan, and it is part of why the second dose gets booked.
• Quote CDC on who should not get it now: a person with a severe allergic reaction to the vaccine or a prior dose, a person who has shingles now, and a person who is pregnant.
• Do not quote effectiveness figures unless they are CDC’s own, attributed with the page date and the age group they describe.

Pneumococcal vaccine pages

Search suggestions use “pneumonia vaccine” more than “pneumococcal vaccine”, so a page can use both terms, but it should explain that the vaccine protects against pneumococcal bacteria, which cause some pneumonia and other serious infections, and not all pneumonia. CDC recommends pneumococcal vaccination for all adults 50 or older and for adults 19 through 49 with certain risk conditions. The CDC Pneumococcal Vaccine Recommendations page for clinicians (February 25, 2026, read through an archived copy) sets out that the vaccine choice and the number of doses depend on what the person has had before.

That last point is what makes searches about the pneumonia vaccine schedule hard to answer on a marketing page. Do not give one interval for everyone. Say the number of doses depends on age, health and past vaccines, that the practice checks the patient’s records, and that the clinician decides. Ask patients to bring their vaccine records, and say where the practice looks them up, such as the state immunization registry, where state law allows it.

RSV vaccine pages

RSV pages draw the “rsv vaccine for adults”, “rsv vaccine age” and “rsv vaccine for seniors” searches. Answer with the CDC wording and date: all adults 75 and older; adults 50 through 74 at increased risk of severe RSV illness, with the note about the court case for ages 50 through 59; a single dose; not an annual vaccine; no second dose at this time; best given in late summer or early fall. The CDC page lists chronic heart or lung disease, a weakened immune system, certain other medical conditions and living in a nursing home among the risk factors. A page can quote that list and say the clinician reviews the patient’s own history.

Keep these points:

• Do not run an RSV campaign as a yearly fall reminder for the same patients. Check records first, and do not invite a patient who has already had an RSV vaccine.
• Do not call the vaccine “recommended for everyone over 50”. Use the CDC age groups and the risk wording, and let the clinician decide who is at increased risk.
• Keep RSV pages for older adults separate from RSV pages for pregnancy or infants, which follow different CDC guidance and are outside this guide.
• Say that FDA has added a Guillain-Barré syndrome warning to the prescribing information of two RSV vaccines, as FDA’s January 2025 notice states, and that the clinician will discuss side effects. Do not repeat FDA’s case estimates on a marketing page.

Pharmacies, senior living and vaccine events

Adult vaccines are given in doctor’s offices, pharmacies, senior living communities and health fairs, and each setting has its own marketing problems. Who can give which vaccine to whom is set state by state for pharmacists, nurses and other staff, and the CRS report notes that state rules on which providers can give certain vaccines reference ACIP or CDC recommendations, so the court case can reach those rules too. Check the rule before a page says “no appointment, no prescription needed” or names an age.

For an event at a senior living community, an employer or a church, keep these points:

• Get each person’s own consent and vaccine history at the event, check eligibility for each vaccine, and send a record to the person’s own clinician with their agreement.
• Plan the second shingles dose before the event, with a date and place, so the series is not left at one.
• Do not collect Medicare numbers or health details on a sign-up sheet or an online form that is not covered by a written agreement; our guide to health fair and screening event marketing covers events.
• At a senior living community, the community’s staff are not the practice’s marketers. Do not pay them per resident signed up, and follow the partner section below.

Supplements and immune boosters

Vitamin packs and “immune support” products sold next to vaccines need the same care as any health claim. The FDA Questions and Answers on Dietary Supplements (content current as of August 27, 2026) says FDA does not have the authority to approve dietary supplements before they are marketed. Name no product, make no claim that a supplement prevents shingles, pneumonia or RSV or replaces a vaccine, and follow our guide to selling supplements in a medical practice.

Recall texts, letters and reminders

Outreach programs reach patients through recall lists: patients 50 and older with no shingles vaccine on file, patients due for a second shingles dose, patients 50 and older with no pneumococcal vaccine on record, and patients 75 and older, or 50 through 74 with a risk condition, with no RSV vaccine on record. Under 45 CFR 164.501, a communication about the practice’s own treatment for an individual, such as a reminder to come in for a recommended vaccine, can fall outside the definition of marketing, while a message that promotes a third party’s product or service generally needs a signed authorization under 45 CFR 164.508.

The words in the message matter as much as the rule. Risk-based lists are built from diagnoses, and a text, a postcard or a voicemail can be seen by a partner, a family member or an employer. Keep these points:

• Name no condition and no reason the patient qualifies. Write “[Practice name]: you may be due for a recommended vaccine. Call [phone] or book online.” and give details only after the patient signs in or calls.
• Do not write “because of your heart condition”, “for people with weakened immune systems” or a medication name on a postcard, an envelope, a caller ID name or a voicemail.
• A second dose reminder can say “[Practice name]: your next vaccine visit is due. Call [phone] to book.” without naming the vaccine if the patient has not agreed to that detail.
• Check records before an RSV reminder goes out, so a patient who has had one is not invited again.
• Send messages in the language the patient chose, use the contact method the patient chose, and honor opt-out requests in every channel.
• Do not send recall lists or vaccine records to an ad platform to build an audience.

Our guides to text message appointment reminders and the patient recall system cover consent, timing and opt-outs.

Coverage, costs and free shots

Coverage pages draw the “shingles vaccine cost” search, and Medicare splits these vaccines between two parts. Medicare.gov says Part B covers pneumococcal vaccines and the person pays nothing if the provider accepts assignment for giving the vaccine. It says Part D covers the shingles and RSV vaccines and the person pays nothing if they have Part D, and that Medicare Advantage plans that include drug coverage also cover the RSV vaccine. Under 42 U.S.C. 1395w-102(b)(8), for plan years from 2023, Part D applies no deductible and no cost sharing to an adult vaccine licensed for adults and given in accordance with ACIP recommendations. Describe each in those terms. A person with no Part D coverage does not get the Part D rule, so “free with Medicare” is wrong for that person.

How a doctor’s office bills a Part D vaccine is a separate question from what Medicare.gov tells the patient. Ask the billing staff how the office bills each Part D plan before a page says a patient pays nothing at the office, and say the practice checks coverage before the visit. Medicare messaging follows our guides to marketing to Medicare patients and Medicare Advantage marketing in a provider office.

Private plans follow 42 U.S.C. 300gg-13, which requires group health plans and health insurers to cover, without cost sharing, immunizations that have in effect an ACIP recommendation with respect to the individual involved. Because the rule turns on the recommendation in effect for that person, and the court case has put one recommendation in question, do not write “free under the ACA” or “covered by all insurance”; say the practice checks coverage before the visit. Cash prices for a vaccine follow our guides to advertising cash prices and good faith estimates for self-pay patients.

A “free” vaccine, a gift card for getting the shot or a raffle at a vaccine event follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and that the terms of the offer should be stated at the outset. Under 42 U.S.C. 1320a-7a(a)(5), civil penalties can apply to a person who offers or transfers remuneration to a Medicare or state health care program beneficiary that the person knows or should know is likely to influence the beneficiary to order or receive items or services from a particular provider, practitioner or supplier. Gift cards and incentives for Medicare patients need counsel’s review before they run.

Partners, sponsors and referral payments

Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Rules on referral fees are also set state by state.

For an adult vaccine program, keep these points:

• Do not accept free vaccine, staff, event funding or marketing help from a vaccine maker or distributor tied to the doses the practice orders or gives, without counsel’s review; our guide to Open Payments covers reported payments from manufacturers.
• Do not pay a senior living community, an employer, a pharmacy or an outreach worker per person vaccinated or signed up, and do not accept payment from a pharmacy for sending patients there for Part D vaccines, without counsel’s review.
• If the practice and a pharmacy share patients for vaccines, put the terms in writing, let the patient choose where to go, and follow our guide to patient and physician referrals.

Privacy, pixels and ads

A visit to a vaccine page for people with weakened immune systems, a risk question on a booking form or an eligibility quiz can say something about the person’s health. Keep form answers, bookings and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place, language settings and search terms, and should not be built from a list of patients with a condition or of patients who have not been vaccinated.

Tone and patient stories

Older adults hear a steady stream of health warnings, and fear and pressure can make some ignore a vaccine message rather than act on it. Lead with what the vaccine prevents, who CDC recommends it for and how simple the visit can be, list side effects plainly, offer times that suit people who rely on others for rides, and keep fear out of it: no photos of rashes or hospital beds, no countdowns, no wording that shames a person who has not been vaccinated. Respect a patient who declines, and say the clinician will answer questions. Offer the page in the languages the practice’s patients speak; our guide to Spanish language medical marketing covers translation.

A story from a patient who had shingles before the vaccine, or who got the vaccine and booked the second dose, can carry the message. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. A story that says the vaccine kept someone out of the hospital is that kind of claim. Pair the story with the attributed CDC statement, say results differ, and get a signed authorization under 45 CFR 164.508 where the practice is a covered entity. A story should not name a diagnosis, a treatment or a result unless the patient chose to share it in writing; say if the person received anything for taking part, and let them review the final version. Our guides to patient photo consent and testimonials and before and after photos cover the full rules.

Illustration: two adult vaccine outreach messages

Illustration: a flyer reads “Over 50? Get all three shots today, free with Medicare! The shingles shot also prevents dementia, the pneumonia shot means no more pneumonia, and the RSV shot is approved for all adults, so get it every fall. Zero side effects. Bring a friend and both get a gift card.” It mixes up who each vaccine is for, adds a claim the CDC pages do not make, says the pneumococcal vaccine prevents all pneumonia, misstates the RSV age range and calls a single dose yearly, denies side effects, states coverage as free for everyone, and offers gift cards without counsel’s review.

Illustration: a second flyer for the same practice reads “Age 50 or older? CDC recommends vaccines against shingles and pneumococcal disease for adults 50 and older, and an RSV vaccine for adults 75 and older and for some adults 50 to 74 at higher risk. At [Practice name], [Clinician name, license] reviews your records and answers your questions. Medicare Part B covers pneumococcal vaccines, and Part D covers shingles and RSV vaccines; we check your coverage before the visit. Sick now or have a rash? Call [phone] before you come in. Call 911 for an emergency. Call [phone] during [days and hours] to book.” It names the federal source, keeps the age groups as CDC writes them, describes coverage by part without a promise, leaves the decision with the clinician, and puts the sick and emergency lines in plain view.

Checklist before an adult vaccine campaign goes live

• Vaccine copy built on the CDC pages, named and dated, with CDC’s age groups, dose counts and side effect lists for shingles, pneumococcal and RSV vaccines, and no promise that a vaccine prevents every case.
• RSV pages for adults 50 through 59 checked against the current CDC guidance and the state of the ACIP court case on the day the page is written, with the date recorded in the page’s review notes; counsel asked before any page calls that recommendation settled.
• No dementia claim, no “no more pneumonia” claim, no “every fall” RSV wording, no “no side effects” wording, and no FDA label age range used to widen the CDC recommendation; no brand names.
• The sick, rash, reaction and 911 lines on pages, flyers, event cards, voicemail, after-hours greetings, portal replies, text replies, chat and AI front desk tools, reviewed by the practice’s clinicians.
• Recall texts, postcards, caller ID names and voicemails name no condition and no reason the patient qualifies; records checked before RSV invitations; second shingles dose reminders scheduled; opt-outs honored.
• Medicare coverage described as Medicare.gov states it, Part B for pneumococcal and Part D for shingles and RSV; Part D billing at the office confirmed with billing staff; private plan coverage checked per patient.
• Free shots, gift cards and raffles reviewed by counsel under 16 CFR 251.1 and 42 U.S.C. 1320a-7a(a)(5).
• Events plan consent, records, eligibility checks, second doses and follow-up; state rules on who can give which vaccine checked.
• No free vaccine, staff or funding from vaccine makers tied to orders, and no per-person payments to communities, employers or pharmacies, without counsel’s review.
• No supplement claims; form answers, bookings and patient lists stay out of pixels and ad audiences; stories have signed authorizations and say results differ.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including primary care, internal medicine, geriatric, pulmonology and pharmacy practices. For an adult vaccine program, that means a site that builds its vaccine pages on the CDC pages as written and dated, notes where the ACIP court case touches a recommendation, explains Medicare Part B and Part D coverage without a promise, puts the sick and 911 lines above the booking button, works for older readers, and answers “shingles vaccine age” and “rsv vaccine for adults” searches honestly, plus appointment request pages that book the visit and keep health answers off the web and away from tracking tools. Our front desk tools hand reaction questions to a clinician or the on-call line, emergencies to the 911 line, and eligibility questions to a clinician, and do not tell patients whether they need a vaccine. We do not decide who should be vaccinated or with what; your clinicians and patients do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• CDC: Adult Immunization Schedule by Age (2025 schedule, addendum updated July 2, 2025)
• CDC: Adult Immunization Schedule Addendum (updated July 2, 2025)
• CDC: Shingles Vaccination (July 19, 2024)
• CDC: Pneumococcal Vaccination (February 25, 2026)
• CDC: Pneumococcal Vaccine Recommendations (February 25, 2026)
• CDC: RSV Vaccine Guidance for Adults (February 20, 2026)
• CDC: ACIP Meeting Information (updated October 9, 2026)
• Congressional Research Service: The 2026 Childhood Immunization Schedule (June 11, 2026)
• Congressional Research Service: CDC’s Updated Childhood Vaccine Schedule: Litigation and Potential Implications for Vaccine Injury Compensation Program (May 4, 2026)
• FDA: Vaccines Licensed for Use in the United States (content current as of October 8, 2026)
• FDA: Guillain-Barré syndrome warning in the prescribing information for two RSV vaccines (content current as of January 7, 2025)
• Medicare.gov: Pneumococcal vaccines (checked October 30, 2026)
• Medicare.gov: Shingles vaccines (checked October 30, 2026)
• Medicare.gov: Respiratory Syncytial Virus (RSV) Shot (checked October 30, 2026)
• 42 U.S.C. 1395w-102: Prescription drug benefits
• 42 U.S.C. 300gg-13: Coverage of preventive health services
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7a: Civil monetary penalties
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing